医学
心力衰竭
药物治疗
重症监护医学
射血分数
梅德林
射血分数保留的心力衰竭
心脏病学
光学(聚焦)
患者依从性
临床试验
医学文献
加权
物理疗法
内科学
钥匙(锁)
临床决策
药物治疗
作者
Aaryan Dwivedi,Zachary L. Cox,Nathaniel Mark Hawkins,Nima Moghaddam,Margaret Sidsworth,Sean Virani,Douglas S. Lee,Ricky D. Turgeon
标识
DOI:10.1161/circheartfailure.125.013881
摘要
BACKGROUND: Guideline-directed medical therapy (GDMT) is central to the care of heart failure with reduced ejection fraction, yet no standard metric exists to quantify its implementation. METHODS: We conducted a scoping review to catalogue and characterize all published heart failure GDMT scores and summarize their application in clinical studies. We searched MEDLINE, Embase, the Central Register of Controlled Trials (CENTRAL), and Web of Science from October 2020 to March 2025. RESULTS: From 544 records, we included 26 studies (19 cohorts, 7 randomized trials; 354 281 patients). Of the 26 studies, 25 (96%) utilized different scores, including 13 adaptations of the Optimal Medical Therapy score originally proposed by the Heart Failure Collaboratory in 2020. All counted RASi (renin-angiotensin system inhibitors), beta-blockers, and mineralocorticoid receptor antagonists; 18 separated sacubitril-valsartan from other RASi, 15 incorporated sodium-glucose cotransporter-2 inhibitors, and 8 captured additional drug classes. Only 2 scores were adjusted for contraindications or intolerance. Across studies, GDMT scores served as a descriptor (N=14), covariate (N=11), predictor of future outcomes (N=12), and end point for GDMT optimization interventions (N=8). CONCLUSIONS: Multiple, disparate scores have been developed to quantify heart failure with reduced ejection fraction GDMT optimization, undermining the original intent. Key gaps in scores include heterogeneous weighting of drug classes and doses, minimal incorporation of intolerance to identify maximum-tolerated therapy, and heterogeneous incorporation of therapies beyond quadruple therapy. Future studies should focus on clear reporting and justification of the selected GDMT score, and the use of existing scores that incorporate relevant contemporary agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI